NCT04326166Unknown不适用
Multi-center, Open, Non-intervention and Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab. in Patients With Type 2 Diabetes
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 入组人数
- 1,971
- 试验地点
- 1
- 主要终点
- Change in HbA1c
研究概览
简要总结
Multi-center, open, non-intervention and observational study to Evaluate the efficacy and safety of Suganon tab. or Sugamet XR tab. in patients with Type 2 diabetes
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 19 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The subject is aged ≥19 years
- •The subject has type 2 diabetes mellitus
排除标准
- •The subject has a contraindication
研究组 & 干预措施
Group A
Patients who receive Double therapy or Insulin
干预措施: Evogliptin (Drug)
Group B
Patients who receive DPP-4 inhibitor
干预措施: Evogliptin (Drug)
Group C
Drug-naïve patients
干预措施: Metformin and Evogliptin (Drug)
结局指标
主要结局
Change in HbA1c
时间窗: at 12 weeks
To assess change from baseline in HbA1c
次要结局
- Change in HbA1c(at 24 weeks)
- Change in FPG(at 12 and 24 weeks)
- The percentage of patients with HbA1c <7.0% and <6.5%(at 12 and 24 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine TumorsPancreatic Neuroendocrine TumorsNCT02282059Pfizer100
已完成
不适用
Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real WorldGastrointestinal Stromal TumorsNCT05381753CStone Pharmaceuticals61
已完成
3 期
A Study to Assess the Efficacy and Safety of IGIV-C in Patients With Myasthenia Gravis ExacerbationsMyasthenia Gravis ExacerbationsNCT02413580Grifols Therapeutics LLC49
已完成
不适用
An Observational Study of Erlotinib (Tarceva) as Second-line Treatment in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Failure of Pemetrexed in First-line TherapyNon-Squamous Non-Small Cell Lung CancerNCT01664533Hoffmann-La Roche57
已完成
不适用
Investigation of Preservative-Free Ophthalmic Solution in Ocular DrynessDry Eye SyndromesNCT05778942SIFI SpA35
